A. Lopez

Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level.

A. J. López, J. Arellano, R. G. Sarmiento, 1999, Mediators of inflammation.

Oncogenic KrasG12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8+ T cells dependent manner

A. Maitra, R. Kalluri, T. Heffernan, 2023, bioRxiv.

Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib

Justin K. Huang, P. Mandal, Jason P. Burke, 2020, Cancer Research.

KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells.

A. Maitra, R. Kalluri, T. Heffernan, 2023, Cancer cell.